Henry Schein

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgicals, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial on a non-recourse basis, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Henry Schein reports solid Q4 performance and anticipates growth

Henry Schein's Q4 performance showcased growth amidst challenges, with a strategic focus on core margin expansion and strong performance in dental specialties. While facing challenges from declining PPE sales and supply chain issues, the company sees opportunities in stable dental markets and continued growth in operating income. Overall, the company remains optimistic about its outlook for 2023.

Henry Schein reports strong Q1 earnings, eyes growth through acquisitions

Henry Schein's Q1 2023 earnings call highlighted strong financial performance across its dental, medical, and Technology and Value-Added Services businesses. While facing challenges from declining PPE and COVID-19 test kit sales, the company remains optimistic about growth opportunities through acquisitions and stable business segments.

Henry Schein reports solid Q2 results, eyes growth opportunities

Henry Schein's Q2 performance was driven by strong dental sales, while facing challenges from declining PPE and COVID test kit sales. The company is focused on strategic acquisitions and expanding product offerings, with opportunities in technology and specialty products driving growth.

Henry Schein navigates post-cyber incident challenges, focuses on recovery

Henry Schein faced challenges from a cybersecurity incident impacting operations but showcased resilience and recovery efforts across its business segments.
Strategic initiatives focused on customer retention, operational efficiency, and cybersecurity response highlight the company's commitment to long-term growth and stability.
Despite challenges in specific segments and cybersecurity spending variables, Henry Schein's focus on recovery, cost-cutting, and customer trust positions it for future opportunities.
The company's emphasis on digital channels, stable medical demand, and strategic cost-cutting measures underscores its adaptability and strategic vision for sustained growth.

Henry Schein reports resilient Q4 performance and outlines 2024 guidance

Henry Schein's Q4 2023 performance reflects resilience amidst challenges, with a strategic focus on technology, global sales, and recovery post-cyber incident. The company's 2024 outlook includes managing residual cyber impacts and pursuing growth opportunities.

Henry Schein reports solid Q1 earnings, eyes market share expansion

Henry Schein's Q1 performance reflects resilience and growth across key segments, with a focus on market share expansion and profitability. While facing challenges in dental consumables and pricing stability, the company is leveraging opportunities in product portfolio expansion and market positioning. Strategic acquisitions and recovery efforts post-cyber incident are driving competitive strength and customer loyalty.

Henry Schein reports mixed Q2 performance, focuses on cost savings

Henry Schein navigated challenges from a cyber incident, with mixed performance across segments in Q2 2024.
Strong sales growth in dental specialties, focus on cost savings, and resilience in technology services were highlights.
The company's strategic initiatives, financial guidance update, and confidence in future prospects were key takeaways from the call.

Henry Schein excels in Q3 with strategic growth initiatives

Henry Schein's Q3 performance reflects strong market positioning and strategic execution, driving growth across key business segments.
While facing challenges such as LCI sales decline, the company's focus on operational efficiency and cost management remains a priority.
With increased sales guidance, ongoing restructuring initiatives, and strategic capital allocation plans, Henry Schein is poised for continued success and expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced its support for two Mission of Mercy events scheduled through 2021, part of the Company's three-year commitment to America's Dentists Care Foundation (ADCF). Henry Schein's support includes donations up to $600,000 in health care products to assist in the delivery of free oral care to underserved and underrepresented communities. The Mission of Mercy (MOM) events will take place in Pittsburgh, PA (10/22-10/23) an

Henry Schein Announces Support for Mission of Mercy Events

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to present at Credit Suisse virtual health care conference on November 9, 2021.

Henry Schein to Present at Credit Suisse Virtual Healthcare Conference

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to webcast third quarter 2021 conference call on November 2, 2021.

Henry Schein to Webcast Third Quarter 2021 Conference Call on Tuesday, November 2, 2021 at 10:00 a.m. ET

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein CEO Stanley Bergman issues statement supporting primary-care physicians access to COVID-19 vaccines.

Henry Schein CEO Stanley M. Bergman Issues Statement Supporting Primary-Care Physician Access to COVID-19 Vaccines

This firm overcame a decline in dental services and supply chain challenges to take market share in 2020. Henry Schein's high-touch business adds considerable value to smaller dental and medical operations that have limited administrative staff and inventory storage.

Henry Schein Creates Value For Customers And Shareholders

Widespread network and channel mix along with favorable long-term trends in the dental business bode well for Henry Schein (HSIC).

Henry Schein (HSIC) Dental Sales Grow Globally Despite Pandemic

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein's Practice Pink Program Celebrates 15th Anniversary Supporting the Global Fight Against Cancer

Henry Schein's Practice Pink Program Celebrates 15th Anniversary Supporting the Global Fight Against Cancer

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein announced a series of legal team promotions.

Henry Schein Announces Legal Team Promotions

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) is helping children around the world return to the classroom through its 24th annual “Back to School” program. This year, Team Schein Members at 22 locations in the U.S., Canada, Spain, and Ireland are donating backpacks filled with school supplies to almost 4,500 children. Since the program's inception in 1998, the Company has helped more than 60,000 children start a new school year with confidence. At each Henry Schein locatio

Henry Schein's 24th Annual ‘Back to School' Program Helps Children in Need Return to the Classroom

Henry Schein's (HSIC) new organizational structure will continue to enhance the company's exposure to faster-growing and higher-margin markets.

Henry Schein (HSIC) Betters Strategic View With Restructure Plan

Align Technology

3D Systems

DENTSPLY SIRONA

These four dental stocks look attractive, as the orthodontics market is positioned for healthy growth in the next few years. The post 4 Dental Stocks to Buy for a Teeth-Straightening Boom appeared first on InvestorPlace.

4 Dental Stocks to Buy for a Teeth-Straightening Boom

Becton, Dickinson and Co.

Veeva Systems

Technology-based healthcare stocks like Henry Schein (HSIC), Veeva Systems (VEEV) and BD (BDX) are expected to continue their rally over the next few months.

Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on

Merit Medical Systems

West Pharmaceutical Services

Let's keep a watch on three lucrative stocks, WST, HSIC and MMSI, in the dental space that investors can add to their watchlist backed by robust long-term prospects.

3 Dental Stocks Poised to Perform Well in Second-Half 2021

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer.

Henry Schein Names Graham Stanley Vice President of Investor Relations and Strategic Financial Project Officer

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein announced a new distribution leadership structure to enhance customer experience and drive operational performance.

Henry Schein Announces New Distribution Leadership Structure to Enhance Customer Experience and Drive Operational Performance

Cooper Companies

HSIC vs. COO: Which Stock Is the Better Value Option?

HSIC or COO: Which Is the Better Value Stock Right Now?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

Why Is Henry Schein (HSIC) Down 0.8% Since Last Earnings Report?

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein opens customer assistance hotline in response to Hurricane Ida.

Henry Schein Opens Customer Assistance Hotline in Response to Hurricane Ida

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to present at two virtual investor conferences in September.

Henry Schein to Present at Two Virtual Investor Conferences in September

KANSAS CITY, Mo.--(BUSINESS WIRE)--The National Association of Intercollegiate Athletics (NAIA) announced on Thursday that it has come to terms with Henry Schein Medical – the medical business of Henry Schein, Inc. – as its ‘Official Sports Medicine Partner' through June 2022. The one year agreement will provide NAIA members a discounted rate for sports medicine services on their campuses, giving institutions an affordable option of medical services for their student-athletes. Supplies can be s

NAIA Announces Partnership with Henry Schein

CONMED

HSIC vs. CNMD: Which Stock Is the Better Value Option?

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers across the eastern United States that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused Tropical Storm Henri. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein Members from 8 a.m. to 6 p.m

Henry Schein Opens Customer Assistance Hotline in Response to Tropical Storm Henri

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein announces new $1 billion credit facility.

Henry Schein Announces New $1 Billion Credit Facility

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein is partnering with NGOs to provide health care products to aid Haitian earthquake victims and is opening its disaster relief fund.

Henry Schein Partners With NGOs to Provide Health Care Products to Aid Haitian Earthquake Victims and Opens Disaster Relief Fund

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Opens Customer Assistance Hotline in Response to the Dixie Fire in Northern California

News for Henry Schein Stock (HSIC)